Scilex Holding Co | - | 4.24% | - | - | 0 |
Gritstone Bio Inc | - | 0.00% | - | - | 0 |
Dyne Therapeutics Inc Ordinary Shares | - | 0.00% | - | - | 0 |
BioNTech SE ADR | - | 0.00% | - | - | 0 |
BeiGene Ltd ADR | - | 0.00% | - | - | 0 |
Avidity Biosciences Inc Ordinary Shares | - | 0.00% | - | - | 0 |
Arrowhead Pharmaceuticals Inc | - | 0.00% | - | - | 0 |
Arcturus Therapeutics Holdings Inc | - | 0.00% | - | - | 0 |
Arbutus Biopharma Corp | - | 0.00% | - | - | 0 |
Alnylam Pharmaceuticals Inc | - | 0.00% | - | - | 0 |
As of April 27, 2023, Direxion Shares ETF Trust - Direxion mRNA ETF has gone out of business. Direxion Shares ETF Trust - Direxion mRNA ETF is an exchange traded fund launched by Direxion Investments. The fund is managed by Rafferty Asset Management, LLC. It invests in public equity markets of global region. The fund invests in stocks of companies operating across development and application of messenger RNA or the mRNA technology sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the BITA Messenger RNA Technology Index, by using full replication technique. Direxion Shares ETF Trust - Direxion mRNA ETF was formed on December 9, 2021 and is domiciled in the United States.